Oneness Biotech Co., Ltd.(TW:4743)
NT$46.25-0.85 (-1.80%)
TW:4743
Oneness Biotech Co., Ltd. financials statements
NT$46.25
At close:-0.85 (-1.80%)
Oneness Biotech Co., Ltd. (4743) Ratios
Oneness Biotech Co., Ltd. Ratios
TW:4743's free cash flow for Q2 2026 was NT$-121.18M. For the 2026 fiscal year, TW:4743's free cash flow was decreased by NT$-1.09M and operating cash flow was NT$-120.08M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 11.81 | 39.87 | 37.23 | 39.47 | 51.21 |
| Quick Ratio | 11.60 | 39.23 | 36.66 | 38.92 | 50.58 |
| Cash Ratio | 3.18 | 5.73 | 3.77 | 27.11 | 2.12 |
| Solvency Ratio | -0.57 | -0.83 | -1.00 | 1.22 | -0.13 |
| Operating Cash Flow Ratio | -0.86 | -1.89 | -1.96 | -4.22 | -1.84 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | -8009.10 | -381.63 |
| Net Current Asset Value | NT$ 4.90B | NT$ 6.43B | NT$ 7.15B | NT$ 7.53B | NT$ 6.41B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 |
| Debt-to-Equity Ratio | 0.04 | 0.03 | 0.03 | 0.02 | 0.02 |
| Debt-to-Capital Ratio | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.14 | 1.11 | 1.09 | 1.07 | 1.12 |
| Debt Service Coverage Ratio | -53.09 | -71.70 | -116.39 | 32.62 | -37.23 |
| Interest Coverage Ratio | -90.22 | -112.96 | -195.48 | 99.29 | -79.83 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.79 | 0.87 | 0.92 | 0.61 | 0.67 |
| Net Debt to EBITDA | 2.75 | 0.94 | 0.59 | -21.30 | 0.25 |
| Profitability Margins | |||||
| Gross Profit Margin | 27.84% | 53.45% | 37.52% | 79.24% | 68.49% |
| EBIT Margin | -621.89% | -966.81% | -1263.64% | -22.66% | -594.64% |
| EBITDA Margin | -363.29% | -581.47% | -746.27% | 23.76% | -294.56% |
| Operating Profit Margin | -621.89% | -920.42% | -1263.64% | 42.82% | -594.64% |
| Pretax Profit Margin | -817.87% | -974.96% | -1517.90% | 42.38% | -602.09% |
| Net Profit Margin | -809.13% | -988.03% | -1512.82% | 33.78% | -627.72% |
| Continuous Operations Profit Margin | -820.56% | -977.75% | -949.26% | 24.58% | -627.72% |
| Net Income Per EBT | 98.93% | 101.34% | 99.67% | 79.71% | 104.26% |
| EBT Per EBIT | 131.51% | 105.93% | 120.12% | 98.99% | 101.25% |
| Return on Assets (ROA) | -8.90% | -8.53% | -8.55% | 2.31% | -2.62% |
| Return on Equity (ROE) | -10.11% | -9.47% | -9.34% | 2.46% | -2.95% |
| Return on Capital Employed (ROCE) | -7.16% | -8.05% | -7.24% | 2.97% | -2.51% |
| Return on Invested Capital (ROIC) | -7.13% | -8.03% | -7.22% | 2.31% | -2.51% |
| Return on Tangible Assets | -9.73% | -9.34% | -9.66% | 2.67% | -3.11% |
| Earnings Yield | -3.92% | -2.79% | -1.50% | 0.40% | -0.40% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.91 | 6.43 | 3.37 | 32.34 | 0.51 |
| Payables Turnover | 25.87 | 20.10 | 31.84 | 156.63 | 11.88 |
| Inventory Turnover | 0.84 | 0.47 | 0.44 | 1.94 | 0.21 |
| Fixed Asset Turnover | 0.13 | 0.11 | 0.07 | 1.03 | 0.06 |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.07 | 0.00 |
| Working Capital Turnover Ratio | 0.02 | 0.02 | 0.01 | 0.13 | 0.01 |
| Cash Conversion Cycle | 823.67 | 817.38 | 927.82 | 197.15 | 2403.82 |
| Days of Sales Outstanding | 403.20 | 56.76 | 108.39 | 11.29 | 714.81 |
| Days of Inventory Outstanding | 434.59 | 778.79 | 830.90 | 188.20 | 1719.73 |
| Days of Payables Outstanding | 14.11 | 18.16 | 11.46 | 2.33 | 30.72 |
| Operating Cycle | 837.78 | 835.54 | 939.29 | 199.48 | 2434.54 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.94 | -0.72 | -0.89 | -2.00 | -0.67 |
| Free Cash Flow Per Share | -0.98 | -0.84 | -1.08 | -2.20 | -0.90 |
| Dividend Paid and CapEx Coverage Ratio | -20.44 | -6.49 | -3.27 | -9.88 | -2.88 |
| Capital Expenditure Coverage Ratio | -20.44 | -6.49 | -4.69 | -9.88 | -2.88 |
| Operating Cash Flow Coverage Ratio | -1.21 | -0.85 | -0.98 | -3.34 | -1.02 |
| Operating Cash Flow to Sales Ratio | -3.48 | -2.93 | -4.86 | -0.83 | -4.39 |
| Free Cash Flow Yield | -1.77% | -0.96% | -0.58% | -1.07% | -0.37% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -25.50 | -35.78 | -66.87 | 250.62 | -253.34 |
| Price-to-Sales (P/S) Ratio | 206.37 | 353.51 | 1011.68 | 85.15 | 1587.16 |
| Price-to-Book (P/B) Ratio | 2.58 | 3.39 | 6.25 | 6.21 | 7.45 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -56.59 | -104.52 | -171.40 | -93.52 | -268.20 |
| Price-to-Operating Cash Flow Ratio | -59.36 | -120.63 | -207.96 | -102.99 | -361.31 |
| Price-to-Earnings Growth (PEG) Ratio | 2.39 | 3.00 | 0.15 | -1.35 | -4.76 |
| Enterprise Value Multiple | -54.06 | -59.86 | -134.98 | 337.05 | -538.56 |
| Enterprise Value | 25.36B | 41.05B | 87.42B | 85.34B | 104.33B |
| EV to EBITDA | -54.06 | -59.86 | -134.98 | 337.05 | -538.56 |
| EV to Sales | 196.39 | 348.07 | 1007.29 | 80.09 | 1586.42 |
| EV to Free Cash Flow | -53.85 | -102.91 | -170.66 | -87.96 | -268.07 |
| EV to Operating Cash Flow | -56.49 | -118.77 | -207.06 | -96.87 | -361.14 |
| Tangible Book Value Per Share | 19.79 | 24.33 | 26.85 | 28.95 | 26.77 |
| Shareholders’ Equity Per Share | 21.56 | 25.76 | 29.65 | 33.11 | 32.32 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | 0.22 | -0.04 |
| Revenue Per Share | 0.27 | 0.25 | 0.18 | 2.41 | 0.15 |
| Net Income Per Share | -2.18 | -2.44 | -2.77 | 0.82 | -0.95 |
| Tax Burden | 0.99 | 1.01 | 1.00 | 0.80 | 1.04 |
| Interest Burden | 1.32 | 1.01 | 1.20 | -1.87 | 1.01 |
| Research & Development to Revenue | 2.39 | 7.84 | 10.98 | 0.86 | 12.26 |
| SG&A to Revenue | 1.81 | 1.90 | 2.04 | 0.16 | 1.78 |
| Stock-Based Compensation to Revenue | 0.21 | 0.24 | 0.50 | 0.02 | 0.33 |
| Income Quality | 0.43 | 0.30 | 0.32 | -1.95 | 0.73 |
Currency in TWD
